A study of clinico- laboratory profile of the patients with type II diabetes at rural tertiary health care center

 

Mithun Somaiah C S

 

Assistant Professor, Department of General Medicine, BGS Global Institute of Medical Sciences, No. 67, BGS health and Education city Uttarahalli road, Kengeri, Bengaluru, Karnataka- 560060, INDIA.

Email: drmithun.somaiah4899@gmail.com

 

REFERENCES

1. Chaturvedi N, John H. Fuller and Marja-RittaTaskinen. Differiassociations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes care 2001; 24 (12) : 2071-207
2. Mazzone T. Current concepts and controversies in the pathogenesis, prevention and treatment of the macrovascular complications of diabetes. J Lab Clin. Med. 2000; 135: 437 – 443.
3. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: An Epidemiologic view. Diabetes Metab Rev 1987; 3:463-524.
4. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 1989; 299: 1127-1131.
5. Pekkanen J, Linn S, Heiss G. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without pre-existing cardiovascular disease. N Engl J Med 1990; 322: 1700-1707.
6. Rosengren A, Hagman M, Wedel H, Wilhelmsen L. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: a 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Eur Heart J 1997; 18: 754-761.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 209: 3015-3023.
8. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 179-182.
9. Sowers JR, Epstein M, Frohlic ED. Diabetes, hypertension and cardiovascular diseases and update. Hypertension 2001; 37: 1053-1059.
10. Pirat J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947-1973. Diabetes Metab 1977; 3.
11. The micro albuminuria collaborative study group. Predictions of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven year prospective study. Diabetes 1999; 16: 918-925.
12. Ozder A (2014) Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: A cross-sectional study. Lipids Health Dis 13: 183.
13. Reddy AS, Meera S, William E, Kumar JS (2014) Correlation between glycemic control and lipid profile in type 2 diabetic patients: HbA1c as an indirect indicator of dyslipidemia. Asian J Pharm Clin Res 7: 153-155.
14. Kayode JA, Adediran OS, Agboola S, Adebisi SA, Idowu A, et al. (2010) Lipid profile of type 2 diabetic patients at a rural tertiary hospital in Nigeria. J Diabetes Endocrinol 1: 46-51.
15. Stamouli M, Pouliakis A, Mourtzikou A, Skliris A, Panagiotou I, et al. (2014) Evaluation of the lipid profile in type 2 diabetes mellitus patients in Greece. Clin Lab 60: 1593-600.
16. Das M, Saikia M (2009) Estimation of reference interval of lipid profile in assamese population. Indian J ClinBiochem 24: 190-193.